BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32748747)

  • 1. Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling.
    Zou W; Hu X; Jiang L
    Curr Cancer Drug Targets; 2020; 20(10):779-788. PubMed ID: 32748747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potentials of BDNF/TrkB in Breast Cancer; Current Status and Perspectives.
    Tajbakhsh A; Mokhtari-Zaer A; Rezaee M; Afzaljavan F; Rivandi M; Hassanian SM; Ferns GA; Pasdar A; Avan A
    J Cell Biochem; 2017 Sep; 118(9):2502-2515. PubMed ID: 28230291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
    Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
    Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer.
    Oyama Y; Nagao S; Na L; Yanai K; Umebayashi M; Nakamura K; Nagai S; Fujimura A; Yamasaki A; Nakayama K; Morisaki T; Onishi H
    Anticancer Res; 2021 Aug; 41(8):4047-4052. PubMed ID: 34281873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
    Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
    PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF and its signaling in cancer.
    Malekan M; Nezamabadi SS; Samami E; Mohebalizadeh M; Saghazadeh A; Rezaei N
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2621-2636. PubMed ID: 36173463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF activates TrkB/PLCγ1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis.
    Xu Y; Jiang WG; Wang HC; Martin T; Zeng YX; Zhang J; Qi YS
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5093-5100. PubMed ID: 31298409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7,8-Dihydroxyflavone alleviates apoptosis and inflammation induced by retinal ischemia-reperfusion injury via activating TrkB/Akt/NF-kB signaling pathway.
    Yu A; Wang S; Xing Y; Han M; Shao K
    Int J Med Sci; 2022; 19(1):13-24. PubMed ID: 34975295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer.
    Serafim Junior V; Fernandes GMM; Oliveira-Cucolo JG; Pavarino EC; Goloni-Bertollo EM
    Cytokine; 2020 Dec; 136():155270. PubMed ID: 32911446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.
    Tsai YF; Tseng LM; Hsu CY; Yang MH; Chiu JH; Shyr YM
    PLoS One; 2017; 12(6):e0178173. PubMed ID: 28604807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of exercise training and TrkB blockade on cardiac function and BDNF-TrkB signaling postmyocardial infarction in rats.
    Lee HW; Ahmad M; Weldrick JJ; Wang HW; Burgon PG; Leenen FHH
    Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1821-H1834. PubMed ID: 30311496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-Derived Neurotrophic Factor Regulates Ishikawa Cell Proliferation through the TrkB-ERK1/2 Signaling Pathway.
    Cao M; Niu Q; Xiang X; Yuan C; Iqbal T; Huang Y; Tian M; Zhao Z; Li C; Zhou X
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF/TrkB/Akt Signaling Pathway Epithelial Odontogenic Tumors and Keratocyst: An Immunohistochemical Study Comparative With Dental Germs.
    Dornelles FML; Wagner VP; Fonseca FP; Ariotti C; Carrard VC; Vargas PA; Sánchez-Romero C; Beovide V; Bologna-Molina R; Martins MD
    Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):366-373. PubMed ID: 32941187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
    Yuan Y; Ye HQ; Ren QC
    Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling.
    Kawamura K; Kawamura N; Okamoto N; Manabe M
    Cancer Med; 2013 Dec; 2(6):849-61. PubMed ID: 24403258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.
    Yuan Y; Ye HQ; Ren QC
    Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer.
    Akil H; Perraud A; Jauberteau MO; Mathonnet M
    World J Gastroenterol; 2016 Jan; 22(2):490-500. PubMed ID: 26811602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
    Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
    Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocyte truncated tropomyosin receptor kinase B mediates brain-derived neurotrophic factor anti-apoptotic effect leading to neuroprotection.
    Saba J; Turati J; Ramírez D; Carniglia L; Durand D; Lasaga M; Caruso C
    J Neurochem; 2018 Sep; 146(6):686-702. PubMed ID: 29851427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer.
    Kimura S; Harada T; Ijichi K; Tanaka K; Liu R; Shibahara D; Kawano Y; Otsubo K; Yoneshima Y; Iwama E; Nakanishi Y; Okamoto I
    Lung Cancer; 2018 Jun; 120():98-107. PubMed ID: 29748024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.